AI assistant
Sending…
XBiotech Inc. — Director's Dealing 2021
Jul 12, 2021
34229_dirs_2021-07-12_6ec52078-307c-4d7e-9f0c-1bb8689a7575.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: XBiotech Inc. (XBIT)
CIK: 0001626878
Period of Report: 2021-07-09
Reporting Person: Libby Peter (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-07-09 | Common Shares | M | 25000 | $7.76 | Acquired | 25000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-07-09 | Stock options | $7.76 | M | 25000 | Disposed | 2029-07-10 | Common Stocks (25000) | Direct |
More from XBiotech Inc.
Interim / Quarterly Report
2026
May 14
Annual Report
2026
Apr 29
Major Shareholding Notification
2026
Jan 23
Major Shareholding Notification
2026
Jan 23
Regulatory Filings
2025
Dec 9
Interim / Quarterly Report
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12
Director's Dealing
2025
Nov 12